PnemoNIX in the News

PNEUMONIX MEDICAL RECEIVES NSF SBIR PHASE II GRANT

PneumoNIX has received follow-on Phase II grant from the NSF SBIR to continue the development of their proprietary technology.

Nov 15, 2022

PneumoNIX Medical, a Baltimore-based medtech company focused on preventing complications associated with soft tissue biopsies, announced...

Nov 10, 2019

PneumoNIX Medical was selected to present to Johns Hopkins Hospital, Maryland Department of Commerce and Technology Development...

May 7, 2019

PneumoNIX Medical is 1 of 50 startups nationwide selected to present to the nations top angel investors. The showcase features the most...

Apr 24, 2019

PneumoNIX was selected as 1 of 15 MedTech start-ups to attend VentureWell’s investor readiness program. The program ensures the companies...

Mar 15, 2019

Meet PneumoNIX team at the VentureWell E-team workshop in Boston from Jan. 31st - Feb. 2nd Read more about it.

Nov 26, 2018

Cigarette Restitution Fund

Aug 2, 2018

Read more about the Technology Accelerator Fund.

Jul 15, 2018

Read about it here.

Jul 13, 2018